VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating UBR5 mRNA and m6A levels. Biomol Biomed [Internet]. 2024 Apr. 3 [cited 2024 May 19];. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10358